In this activity, an interprofessional panel of experts review some of the key challenges associated with intravitreal therapy in patients with diabetic macular edema (DME) and neovascular age-related macular edema (nAMD); critical data on recent therapeutic advances designed to reduce the burden of treatment of these diseases are also highlighted. In addition, two patients with a history of DME or nAMD discuss their journey, while the panel highlights the role of the interprofessional care team and navigate the nuances of intravitreal therapy selection.
Upon completion of this activity, participants should be better able to:
Vitreoretinal Surgeon, Ophthalmology
Owner, Star Retina and Star Vision Research
Burleson, TX
Vice Chair, Clinical Affairs
Professor, Ophthalmology
The Byers Eye Institute
Stanford University School of Medicine
Palo Alto, CA
Founder and Chief Executive Officer
Reveles Clinical Services
Southlake, TX
Featured RMEI CE Activities – Earn CE Credit(s)
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources
